Inventor · disambiguated record
Axel Harrenga
Also filed as: HARRENGA AXEL
5 granted patents·16 pending applications·38 citations·filing 2005–2017
78Inventor score
Files withSEATTLE GENETICS INC5BAYER IP GMBH3LERCHEN HANS-GEORG3BAYER HEALTHCARE AG2OTTO CHRISTIANE2
Top patents by PatentIndex Score
21 records- 0192US8992932B2Binder-drug conjugates (ADCs) and use thereofSEATTLE GENETICS INC·Filed 2012·Granted Mar 31, 2015·26 cites·12 claims
- 0280US9777063B2Neutralizing prolactin receptor antibody Mat3 and its therapeutic useBAYER IP GMBH·Filed 2016·Granted Oct 3, 2017·3 cites·4 claims
- 0376US9649374B2Neutralizing prolactin receptor antibodies and their therapeutic useOTTO CHRISTIANE·Filed 2010·Granted May 16, 2017·5 cites·5 claims
- 0468US9241989B2Neutralizing prolactin receptor antibodies and their therapeutic useOTTO CHRISTIANE·Filed 2010·Granted Jan 26, 2016·2 cites·16 claims
- 0566US9353186B2Neutralizing prolactin receptor antibody Mat3 and its therapeutic useFREIBERG CHRISTOPH·Filed 2012·Granted May 31, 2016·2 cites·14 claims
- 0661US2015030618A1Novel binder-drug conjugates (adcs) and use thereofSEATTLE GENETICS INC·Filed 2014·Application pending·0 cites
- 0757US2014127240A1Novel Binder-Drug Conjugates (ADCs) and Use of SameLERCHEN HANS-GEORG·Filed 2012·Application pending·0 cites
- 0857US2013122024A1New binder-drug conjugates (adcs) and use thereofLERCHEN HANS-GEORG·Filed 2012·Application pending·0 cites
- 0956US2013066055A1New binder-drug conjugates (adcs) and use thereofLERCHEN HANS-GEORG·Filed 2012·Application pending·0 cites
- 1056US2016193359A1New binder-drug conjugates (adcs) and use thereofSEATTLE GENETICS INC·Filed 2016·Application pending·0 cites
- 1154US2015246136A1NOVEL BINDER-DRUG CONJUGATES (ADCs) AND USE OF SAMESEATTLE GENETICS INC·Filed 2015·Application pending·0 cites
- 1251US2017158775A1Anti-c4.4a antibodies and uses thereofBAYER IP GMBH·Filed 2017·Application pending·0 cites
- 1348US2010022527A1Biphenyl substituted spirotetronic acids and their use for the treatment of retroviral diseasesAICURIS GMBH & CO KG·Filed 2009·Application pending·0 cites
- 1447US2014322220A1Anti-FGFR2 Antibodies and Uses ThereofBAYER IP GMBH·Filed 2012·Application pending·0 cites
- 1547US2015023989A1New antibody drug conjugates (adcs) and the use thereofSEATTLE GENETICS INC·Filed 2012·Application pending·0 cites
- 1645US2010105673A1Substituted aminofuranones and their useBAYER SCHERING PHARMA AG·Filed 2007·Application pending·0 cites
- 1743US2009170766A1Chimeric Kunitz Domains and their UseBAYER HEALTHCARE AG·Filed 2007·Application pending·0 cites
- 1843US2016237160A1Anti-tweakr antibodies and uses thereofBayer Pharma AG·Filed 2014·Application pending·0 cites
- 1942US2014050743A1Binding proteins to inhibitors of coagulation factorsDITTMER FRANK·Filed 2012·Application pending·0 cites
- 2041US2012321619A1Anti-c4.4a antibodies and uses thereofLINDEN LARS·Filed 2010·Application pending·0 cites
- 2140US2010003709A1Crystal Structure of Enzyme and Uses ThereofBAYER HEALTHCARE AG·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →